HUP0004562A3 - Compositions and methods for increasing the concentration and/or motility of spermatozoa in humans - Google Patents

Compositions and methods for increasing the concentration and/or motility of spermatozoa in humans

Info

Publication number
HUP0004562A3
HUP0004562A3 HU0004562A HUP0004562A HUP0004562A3 HU P0004562 A3 HUP0004562 A3 HU P0004562A3 HU 0004562 A HU0004562 A HU 0004562A HU P0004562 A HUP0004562 A HU P0004562A HU P0004562 A3 HUP0004562 A3 HU P0004562A3
Authority
HU
Hungary
Prior art keywords
spermatozoa
motility
humans
compositions
concentration
Prior art date
Application number
HU0004562A
Other languages
Hungarian (hu)
Original Assignee
Sigma Tau Healthscience Spa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US08/980,821 external-priority patent/US5863940A/en
Application filed by Sigma Tau Healthscience Spa filed Critical Sigma Tau Healthscience Spa
Publication of HUP0004562A2 publication Critical patent/HUP0004562A2/en
Publication of HUP0004562A3 publication Critical patent/HUP0004562A3/en
Publication of HU228989B1 publication Critical patent/HU228989B1/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/205—Amine addition salts of organic acids; Inner quaternary ammonium salts, e.g. betaine, carnitine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/08—Drugs for genital or sexual disorders; Contraceptives for gonadal disorders or for enhancing fertility, e.g. inducers of ovulation or of spermatogenesis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/10—Drugs for genital or sexual disorders; Contraceptives for impotence

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Reproductive Health (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Endocrinology (AREA)
  • Gynecology & Obstetrics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Pregnancy & Childbirth (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
HU0004562A 1997-12-01 1998-11-18 Compositions and methods for increasing the concentration and/or motility of spermatozoa in humans HU228989B1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US08/980,821 US5863940A (en) 1997-12-01 1997-12-01 Medicament and therapeutical method for treating idiopathic asthenozoospermia
US09/122,897 US6090848A (en) 1997-12-01 1998-07-28 Compositions and methods for increasing the concentration and/or motility of spermatozoa in humans
PCT/IT1998/000324 WO1999027925A1 (en) 1997-12-01 1998-11-18 Compositions and methods for increasing the concentration and/or motility of spermatozoa in humans

Publications (3)

Publication Number Publication Date
HUP0004562A2 HUP0004562A2 (en) 2001-05-28
HUP0004562A3 true HUP0004562A3 (en) 2003-05-28
HU228989B1 HU228989B1 (en) 2013-07-29

Family

ID=26820998

Family Applications (1)

Application Number Title Priority Date Filing Date
HU0004562A HU228989B1 (en) 1997-12-01 1998-11-18 Compositions and methods for increasing the concentration and/or motility of spermatozoa in humans

Country Status (23)

Country Link
US (1) US6090848A (en)
EP (1) EP1039894B1 (en)
JP (1) JP2001524520A (en)
KR (1) KR20010032702A (en)
CN (1) CN1184966C (en)
AT (1) ATE206916T1 (en)
AU (1) AU749754B2 (en)
BR (1) BR9814711A (en)
CA (1) CA2314942C (en)
DE (1) DE69802113T2 (en)
DK (1) DK1039894T3 (en)
EE (1) EE200000309A (en)
ES (1) ES2163896T3 (en)
HK (1) HK1033280A1 (en)
HU (1) HU228989B1 (en)
IL (1) IL136299A0 (en)
IS (1) IS5501A (en)
NO (1) NO20002798L (en)
PL (1) PL192438B1 (en)
PT (1) PT1039894E (en)
SK (1) SK7572000A3 (en)
TR (1) TR200001519T2 (en)
WO (1) WO1999027925A1 (en)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR100827900B1 (en) * 1999-09-03 2008-05-07 시그마-타우 헬스사이언스 에스.피.에이 Ultrafine L-Carnitine, Methods of Preparing the Same, Compositions Containing the Same, and Methods of Using the Same
ITRM20010029A1 (en) * 2001-01-23 2002-07-23 Aldo Fassi METALLIC SALTS OF CARNITINE USEFUL AS DIET / NUTRITIONAL SUPPLEMENTS OR AS DRUGS, COMPOSITIONS CONTAINING THEM AND PROCEDURES FOR
LV12978B (en) * 2001-09-07 2003-05-20 Ivars Kalvins Pharmaceutical composition
DK1425033T3 (en) * 2001-09-12 2011-01-10 Merck Serono Sa Use of hCG and LH in controlled ovarian stimulation
IL160780A0 (en) * 2001-09-12 2004-08-31 Applied Research Systems USE OF hCG IN THE MANUFACTURE OF A MEDICAMENT
ITRM20010621A1 (en) * 2001-10-18 2003-04-18 Aldo Fassi NON-HYGROSCOPIC AND WATER SOLUBLE ALCANOYL L-CARNITINE METAL SALTS, DIETARY SUPPLEMENTS THAT CONTAIN THEM AND DIET KITS, FOR CONTRAST
ITRM20020194A1 (en) * 2002-04-09 2003-10-09 Sigma Tau Healthscience Spa USEFUL COMPOSITION TO INCREASE THE CONCENTRATION AND MOTILITY OF SPERMATOZOI AND IMPROVE THE MORPHOLOGY IN MAN.
US7776913B2 (en) 2002-12-13 2010-08-17 Sigma-Tau Industrie Farmaceutiche Riunite S.P.A. Carnitines for treating or preventing disorders caused by andropause
AT503219B1 (en) 2006-02-03 2008-07-15 Annerl Brigitte COMBINATION PREPARATION BASED ON ANTIOXIDANTS TO IMPROVE THE SEED QUALITY
EP2086642B1 (en) * 2006-10-18 2014-06-25 Periness Ltd. Dnase for the treatment of male sub-fertility
DE102007053369A1 (en) 2007-11-09 2009-07-02 Alzchem Trostberg Gmbh Use of a preparation containing a creatine-component and a further component of e.g. L-carnitine, acetyl-L-carnitine, arginine, glutathione, vitamin C and vitamin E, as a dietary supplement for improving the male fertility in vertebrates
WO2009068278A2 (en) * 2007-11-30 2009-06-04 Bayer Consumer Care Ag A pharmaceutical composition
US20110015154A1 (en) * 2009-07-20 2011-01-20 Kellermann Gottfried H Supporting acetylcholine function
US20110098265A1 (en) * 2009-10-28 2011-04-28 Neuroscience, Inc. Methods for reducing cravings and impulses associated with addictive and compulsive behaviors
EP3076958B1 (en) * 2013-12-05 2018-01-10 Alfasigma S.p.A. Composition useful for promoting female fertility
CN105695398A (en) * 2016-04-25 2016-06-22 广西大学 O-acetyl-L-carnitine hydrochloride containing buffalo oocyte in-vitro maturation liquid and culture method
EP3269389B1 (en) * 2016-07-11 2020-05-27 Laboratoire des Granions Composition comprising l-carnitine for the treatment of male infertility
CN107375346A (en) * 2017-07-25 2017-11-24 昭远制药(上海)有限公司 Improve composition of human sperm's concentration and motility and preparation method thereof

Family Cites Families (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1235153B (en) * 1988-11-15 1992-06-22 Sigma Tau Ind Farmaceuti USE OF ACETYL L-CARNITINE IN THE THERAPEUTIC TREATMENT OF CATARACT AND PHARMACEUTICAL COMPOSITIONS USEFUL IN SUCH TREATMENT
IT1224795B (en) * 1988-12-01 1990-10-24 Sigma Tau Ind Farmaceuti USE OF ACETYL D-CARNITINE IN THE THERAPEUTIC TREATMENT OF GLAUCOMA AND PHARMACEUTICAL COMPOSITIONS USEFUL IN SUCH TREATMENT
IT1224842B (en) * 1988-12-27 1990-10-24 Sigma Tau Ind Farmaceuti USE OF L-CARNITINE DERIVATIVES IN THE THERAPEUTIC TREATMENT OF DEGENERATIVE ALTERATIONS OF THE NERVOUS SYSTEM
IT1240760B (en) * 1990-02-12 1993-12-17 Sigma Tau Ind Farmaceuti ACYL-L-CARNITINE ESTERS WITH GAMMA-HYDROXYBUTIRRIC ACID AND PHARMACEUTICAL COMPOSITIONS THAT CONTAIN THEM FOR THE INHIBITION OF NEURONAL DEGENERATION AND IN THE TREATMENT OF COMA.
IT1240799B (en) * 1990-03-15 1993-12-17 Sigma Tau Ind Farmaceuti PHARMACEUTICAL COMPOSITIONS CONTAINING 3-METHYLTHIOPROPIONYL L-CARNITINE FOR ACTIVITY ON THE CARDIOVASCULAR SYSTEM.
IT1244636B (en) * 1991-01-04 1994-08-08 Sigma Tau Ind Farmaceuti USE OF ACETYL L-CARNITINE IN THERAPEUTIC TREATMENT OF COMA AND PHARMACEUTICAL COMPOSITIONS USEFUL IN SUCH TREATMENT.
IT1248323B (en) * 1991-05-16 1995-01-05 Sigma Tau Ind Farmaceuti STARCHES WITH NATURAL AMINO ACIDS OF ALCANOIL L-CARNITINE AS INHIBITORS OF THE NEURONAL DEGENERATION AND ACTIVATORS OF THE LEARNING AND STORING PROCESSES AND FOR THE TREATMENT OF THE COMA AND PHARMACEUTICAL COMPOSITIONS INCLUDING SUCH COMPOUNDS
IT1245699B (en) * 1991-05-29 1994-10-14 Sigma Tau Ind Farmaceuti L-CARNITINE DERIVATIVES AS THERAPEUTIC AGENTS FOR THE TREATMENT OF MYOPATHIES, NEURONAL DEGENARATION AND TO INHIBIT PROTEOLYSIS
IT1249462B (en) * 1991-10-21 1995-02-23 Sigma Tau Ind Farmaceuti USE OF L-CARNITINA AND ACIL L-CARNITINE IN THE TREATMENT OF IDIOPATHIC OLIGOASTENOSPERMIE.
IT1263004B (en) * 1992-10-08 1996-07-23 Sigma Tau Ind Farmaceuti USE OF L-CARNITINE AND ACIL L-CARNITINE IN THE LONG-TERM TREATMENT OF NON-INSULIN-EMPLOYEE DIABETIC PATIENTS.
IT1263013B (en) * 1992-10-20 1996-07-23 Avantgarde Spa ESTERS OF L-CARNITINE AND ALCANOYL L-CARNITINE WITH GLYCOLIC ACID OR ITS ESTERS AND PHARMACEUTICAL COMPOSITIONS CONTAINING SUCH AS FOR THE TREATMENT OF SKIN DISEASES.
IT1261688B (en) * 1993-05-28 1996-05-29 Avantgarde Spa USE OF L-CARNITINE ESTERS ON OXYDRIDE TO PRODUCE PHARMACEUTICAL COMPOSITIONS FOR THE TREATMENT OF SKIN DISEASES.
IT1261696B (en) * 1993-06-02 1996-05-29 Avantgarde Spa USE OF L-CARNITINE ESTERS ON OXYDRIDE WITH AROMATIC ACIDS TO PRODUCE PHARMACEUTICAL COMPOSITIONS FOR THE TREATMENT OF SKIN DISEASES.
IT1261984B (en) * 1993-06-22 1996-06-11 Avantgarde Spa USE OF L-CARNITINE ESTERS OR ACIL L-CARNITINE WITH HYDROXIACID TO PRODUCE PHARMACEUTICAL COMPOSITIONS FOR THE TREATMENT OF SKIN DISEASES.
IT1272290B (en) * 1994-06-20 1997-06-16 Avantgarde Spa SALT OF L-CARNITINE AND PHARMACEUTICAL COMPOSITIONS THAT CONTAIN IT FOR THE TREATMENT OF SKIN DISEASES
IT1274157B (en) * 1994-09-08 1997-07-15 Avantgarde Spa "L-CARNITINE SALT AND PHARMACEUTICAL COMPOSITIONS THAT CONTAIN IT FOR THE TREATMENT OF SKIN DISEASES"
IT1274156B (en) * 1994-09-08 1997-07-15 Avantgarde Spa "L-CARNITINE SALT AND PHARMACEUTICAL COMPOSITIONS THAT CONTAIN IT FOR THE TREATMENT OF SKIN DISEASES"
IT1276225B1 (en) * 1995-10-17 1997-10-27 Sigma Tau Ind Farmaceuti PHARMACEUTICAL COMPOSITIONS CONTAINING L-CARNITINE AND ALKANOYL L-CARNITINE IN ASSOCIATION WITH RESVERATROL OR ITS DERIVATIVES USEFUL FOR
IT1277953B1 (en) * 1995-12-21 1997-11-12 Sigma Tau Ind Farmaceuti PHARMACEUTICAL COMPOSITION CONTAINING L-CARNITINE OR AN ALCANOYL L-CARNITINE AND A 3-OMEGA SERIES POLYUNSATURED ACID USEFUL
US5889055A (en) * 1997-04-04 1999-03-30 Howard; James R. L-carnitine and acetyl-L-carnitine combined for prevention and treatment of syndromes related to diseases of energy metabolism
IT1295408B1 (en) * 1997-10-03 1999-05-12 Sigma Tau Ind Farmaceuti ASSOCIATION OF L-CARNITINE AND ALCANOYL L-CARNITINE FOR THE TREATMENT OF ALCOHOLISM

Also Published As

Publication number Publication date
EP1039894B1 (en) 2001-10-17
CA2314942A1 (en) 1999-06-10
CA2314942C (en) 2009-05-05
TR200001519T2 (en) 2000-11-21
EP1039894A1 (en) 2000-10-04
HUP0004562A2 (en) 2001-05-28
AU1259199A (en) 1999-06-16
HK1033280A1 (en) 2001-08-24
JP2001524520A (en) 2001-12-04
SK7572000A3 (en) 2000-11-07
IL136299A0 (en) 2001-05-20
PL342115A1 (en) 2001-05-21
CN1184966C (en) 2005-01-19
PL192438B1 (en) 2006-10-31
NO20002798L (en) 2000-06-27
US6090848A (en) 2000-07-18
PT1039894E (en) 2002-04-29
ATE206916T1 (en) 2001-11-15
EE200000309A (en) 2001-08-15
ES2163896T3 (en) 2002-02-01
HU228989B1 (en) 2013-07-29
DE69802113T2 (en) 2002-06-06
DE69802113D1 (en) 2001-11-22
NO20002798D0 (en) 2000-05-31
DK1039894T3 (en) 2002-02-11
AU749754B2 (en) 2002-07-04
WO1999027925A1 (en) 1999-06-10
KR20010032702A (en) 2001-04-25
IS5501A (en) 2000-05-19
CN1284871A (en) 2001-02-21
BR9814711A (en) 2000-10-03

Similar Documents

Publication Publication Date Title
PL327658A1 (en) Disinfecting compositions and methods of disinfecting surfaces
HUP0004562A3 (en) Compositions and methods for increasing the concentration and/or motility of spermatozoa in humans
PL344589A1 (en) COMPOSITION COMPRISING β-HYDROXY-β-METHYLBUTYRIC ACID AND AT LEAST ONE AMINO ACID AND METHODS OF USE
HUP0001020A3 (en) Stanol composition and the use thereof
PL327659A1 (en) Disinfecting compositions and surface disinfecting methods
GB2294465A8 (en) Perfluoroelastomeric compositions and methods
EP0946158A4 (en) Skin tanning compositions and method
GB9813271D0 (en) Composition and use
BG105437A (en) Rheoogy modified compositions and processes thereof
ZA989400B (en) Method and composition
PL336349A1 (en) Compositions for and methods for treating and diagnosing the mastocarcinoma
EP1056456A4 (en) R-lansoprazole compositions and methods
HK1033653A1 (en) Synergistic composition and use thereof
DE69724629D1 (en) COMPOSITIONS AND THEIR USE
PL327945A1 (en) Disinfecting compositions and methods of disinfecting surfaces
PL328463A1 (en) Disinfecting composition and surface disinfecting methods
EP1056457A4 (en) S-lansoprazole compositions and methods
PL332616A1 (en) Hydoxymethylhexanones as odorising and savourising agents
IL142635A0 (en) Compositions and methods using lactadherin or variants thereof
EP1006780A4 (en) Two component plant cell lethality methods and compositions
PT826679E (en) COMPOSITIONS OF INTERMEDIATE NAFTILO COMPOSITIONS AND METHODS OF USE
EP1139981A4 (en) Compositions and methods of using the same
GB9803506D0 (en) Composition and method
IL120488A0 (en) Modifiers for water-setting inorganic compositions and modified water-setting inorganic compositions
SI1039894T1 (en) Compositions for increasing the concentration and/or motility of spermatozoa in humans

Legal Events

Date Code Title Description
GB9A Succession in title

Owner name: SIGMA-TAU INDUSTRIE FARMACEUTICHE RIUNITE S.P., IT

Free format text: FORMER OWNER(S): SIGMA-TAU HEALTHSCIENCE S.P.A., IT